Two Receptor Systems Are Involved in the Plasma Clearance of Tissue Factor Pathway Inhibitor in Vivo
Data up to Jan 2025
Total Citations Per Year
Abstract
References (22)
39-kDa protein modulates binding of ligands to low density lipoprotein receptor-related protein/alpha 2-macroglobulin receptor.
1991 • 586 citations
Tissue factor pathway inhibitor reduces mortality from Escherichia coli septic shock.
1993 • 552 citations
Functional significance of the Kunitz-type inhibitory domains of lipoprotein-associated coagulation inhibitor
1989 • 475 citations
Heparin induces release of extrinsic: Coagulation pathway inhibitor (EPI)
1988 • 401 citations
Cloning and characterization of a cDNA coding for the lipoprotein-associated coagulation inhibitor shows that it consists of three tandem Kunitz-type inhibitory domains.
1988 • 331 citations
The low-density lipoprotein receptor-related protein: double agent or decoy?
1991 • 183 citations
The role of tissue factor pathway inhibitor in a revised coagulation cascade.
1992 • 155 citations
Tissue factor pathway inhibitor: the carboxy-terminus is required for optimal inhibition of factor Xa
1992 • 150 citations
Purification and properties of heparin-releasable lipoprotein- associated coagulation inhibitor
1991 • 144 citations
Prevention of arterial reocclusion after thrombolysis with recombinant lipoprotein-associated coagulation inhibitor.
1991 • 123 citations
The low density lipoprotein receptor-related protein mediates the cellular degradation of tissue factor pathway inhibitor.
1994 • 110 citations
Two receptor systems are involved in the plasma clearance of tissue-type plasminogen activator (t-PA) in vivo.
1995 • 84 citations
Recombinant lipoprotein-associated coagulation inhibitor inhibits tissue thromboplastin-induced intravascular coagulation in the rabbit
1990 • 82 citations
Identification of domains on the 39-kDa protein that inhibit the binding of ligands to the low density lipoprotein receptor-related protein.
1993 • 78 citations
39-kD protein inhibits tissue-type plasminogen activator clearance in vivo.
1993 • 75 citations
Identification and partial characterization by chemical cross-linking of a binding protein for tissue-type plasminogen activator (t-PA) on rat hepatoma cells. A plasminogen activator inhibitor type 1-independent t-PA receptor.
1992 • 70 citations
The carboxy terminus of tissue factor pathway inhibitor is required for interacting with hepatoma cells in vitro and in vivo.
1995 • 68 citations
The asparagine-linked oligosaccharides on tissue factor pathway inhibitor terminate with SO4-4GalNAc beta 1, 4GlcNAc beta 1,2 Mana alpha.
1992 • 61 citations
Clearance of Recombinant Tissue Factor Pathway Inhibitor (TFPI) in Rabbits
1992 • 52 citations
Lipoprotein-associated coagulation inhibitor (LACI) is a cofactor for heparin: synergistic anticoagulant action between LACI and sulfated polysaccharides
1992 • 46 citations
Pharmacokinetics of Full Length and Two-Domain Tissue Factor Pathway Inhibitor in Combination with Heparin in Rabbits
1993 • 29 citations
Protamine Neutralization of the Release of Tissue Factor Pathway Inhibitor Activity by Heparins
1993 • 25 citations